glycaemic, Glucokinase, Hexokinase D, Hexokinase IV, HMS-5552, HMS 5552, HMS5552, pancreatic, Inhibitor, inhibit, Dorzagliatin, diabetes, beta-cell, type 2
Dorzagliatin (HMS5552) is a dual-acting glucokinase activator investigated for type 2 diabetes research. It enhances glycemic control and beta-cell function, with studies demonstrating its efficacy in both in vitro enzymatic assays and in vivo animal models of diabetes.
